225 related articles for article (PubMed ID: 7701715)
1. [Prospectives for using the extracorporeal connection of a xenospleen in treating patients with liver cirrhosis and obstructive jaundice complicated by liver failure].
Vakhidov AV; Kasymov ShZ; Kirichenko IP; Nazyrov FG; Kornienko VI; Akbarov MM
Vestn Khir Im I I Grek; 1993; 150(1-2):90-2. PubMed ID: 7701715
[TBL] [Abstract][Full Text] [Related]
2. [Changes in the immunological indices of patients with obstructive jaundice and liver cirrhosis during the extracorporeal connection of a pig spleen].
Arynova RS; Bazhenov LG; Kornienko VI
Klin Khir (1962); 1994; (3):25-7. PubMed ID: 7637283
[TBL] [Abstract][Full Text] [Related]
3. [Extracorporeal connection of a xenospleen in the sepsis patient].
Russkikh IuN
Vestn Khir Im I I Grek; 1994; 152(5-6):59-60. PubMed ID: 7740688
[No Abstract] [Full Text] [Related]
4. Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation -- a pilot study.
Choi JY; Bae SH; Yoon SK; Cho SH; Yang JM; Han JY; Ahn BM; Chung KW; Sun HS; Kim DG
Liver Int; 2005 Aug; 25(4):740-5. PubMed ID: 15998424
[TBL] [Abstract][Full Text] [Related]
5. [Comparative effectiveness of different treatment methods of liver failure].
Kutepov DE; Vershinina MG; Pasechnik IN; Sal'nikov PS
Khirurgiia (Mosk); 2014; (3):32-6. PubMed ID: 24781068
[TBL] [Abstract][Full Text] [Related]
6. Sorbent suspensions vs. sorbent columns for extracorporeal detoxification in hepatic failure.
Ash SR; Sullivan TA; Carr DJ
Ther Apher Dial; 2006 Apr; 10(2):145-53. PubMed ID: 16684216
[TBL] [Abstract][Full Text] [Related]
7. [Comparative assessment of methods of extracorporeal detoxication in obstructive jaundice].
Kochnev OS; Korobkov VN; Malkov IS; Shaĭmardanov RSh; Borisov AP
Khirurgiia (Mosk); 1995; (6):26-9. PubMed ID: 8569116
[TBL] [Abstract][Full Text] [Related]
8. [The extracorporeal connection of a donor spleen in the treatment of anaerobic sepsis].
Rotar' VI; Akent'ev SA; Rusnak AD; Zaĭshliuk PG; Khomko OI
Klin Khir (1962); 1991; (12):24-6. PubMed ID: 1798246
[TBL] [Abstract][Full Text] [Related]
9. [Temporary perfusion substitution of liver and spleen functions in patients with peritonitis].
Bel'kov AV; Pisarevskiĭ AA
Khirurgiia (Mosk); 1993 Nov; (11):42-5. PubMed ID: 8145465
[TBL] [Abstract][Full Text] [Related]
10. [Complex detoxication therapy in obstructive jaundice of tumor genesis].
Dronov AI
Lik Sprava; 2002; (8):81-5. PubMed ID: 12669551
[TBL] [Abstract][Full Text] [Related]
11. [Plasmapheresis in the combined treatment of patients with obstructive jaundice].
Abdullaev EG; Babyshin VV
Vestn Khir Im I I Grek; 1993; 150(1-2):92-5. PubMed ID: 7701716
[TBL] [Abstract][Full Text] [Related]
12. [Biohemosorption on xenospleen as a method for detoxication in burns].
Iarugskiĭ EE; Garib FIu; Saidov AA; Karev VA; Nuraliev NA
Vestn Khir Im I I Grek; 1994; 152(1-2):108-12. PubMed ID: 7701723
[TBL] [Abstract][Full Text] [Related]
13. Albumin regeneration in liver support-comparison of different methods.
Mitzner S; Klammt S; Stange J; Schmidt R
Ther Apher Dial; 2006 Apr; 10(2):108-17. PubMed ID: 16684211
[TBL] [Abstract][Full Text] [Related]
14. [The use of cholesorption in the treatment of patients with acute cholecystitis complicated by cholangitis].
Bondarev VI; Ablitsov NP; Baziak AP; Gorokhov IuA
Klin Khir (1962); 1992; (9-10):37-40. PubMed ID: 1291777
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of acute hepatic failure in mechanical jaundice].
Kozyrev MA
Khirurgiia (Mosk); 1990 Oct; (10):42-5. PubMed ID: 2283750
[TBL] [Abstract][Full Text] [Related]
16. [Extracorporeal xenospleen perfusion in vial-bacterial pneumonia in children].
Kireev SS; Grigor'ev VA; Fukzon AS; Kopylov SM; Bagmut TA
Anesteziol Reanimatol; 1990; (1):36-8. PubMed ID: 2350044
[TBL] [Abstract][Full Text] [Related]
17. [Lympho- and hemosorption in the surgical treatment of hepatic insufficiency].
Kasymov ShZ
Vestn Khir Im I I Grek; 1985 Oct; 135(10):121-3. PubMed ID: 4090179
[TBL] [Abstract][Full Text] [Related]
18. Pro-inflammatory interleukin-18 and Caspase-1 serum levels in liver failure are unaffected by MARS treatment.
Roth GA; Faybik P; Hetz H; Hacker S; Ankersmit HJ; Bacher A; Thalhammer T; Krenn CG
Dig Liver Dis; 2009 Jun; 41(6):417-23. PubMed ID: 19019743
[TBL] [Abstract][Full Text] [Related]
19. [Drainage of the thoracic lymphatic duct and lymphosorption in the combined treatment of obstruction of the bile ducts and liver failure].
Shalimov SA; Zemskov VS; Kolesnikov EB
Vestn Khir Im I I Grek; 1982 Feb; 128(2):24-9. PubMed ID: 7072053
[TBL] [Abstract][Full Text] [Related]
20. Technology insight: artificial extracorporeal liver support--how does Prometheus compare with MARS?
Krisper P; Stauber RE
Nat Clin Pract Nephrol; 2007 May; 3(5):267-76. PubMed ID: 17457360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
